MX162717A - Procedimiento para la obtencion de un derivado de 2-pirrolidona - Google Patents

Procedimiento para la obtencion de un derivado de 2-pirrolidona

Info

Publication number
MX162717A
MX162717A MX2417A MX241786A MX162717A MX 162717 A MX162717 A MX 162717A MX 2417 A MX2417 A MX 2417A MX 241786 A MX241786 A MX 241786A MX 162717 A MX162717 A MX 162717A
Authority
MX
Mexico
Prior art keywords
derivative
pirrolidone
procedure
obtaining
alkylene
Prior art date
Application number
MX2417A
Other languages
English (en)
Inventor
Hironori Ikuta
Youji Yamagishi
Kozo Akasaka
Isao Yamatsu
Seiichi Kobayashi
Hiroshi Shirota
Kouichi Katayama
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of MX162717A publication Critical patent/MX162717A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/382-Pyrrolones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2632-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/272-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/50Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MX2417A 1985-05-09 1986-05-08 Procedimiento para la obtencion de un derivado de 2-pirrolidona MX162717A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60096799A JPH066571B2 (ja) 1985-05-09 1985-05-09 2−ピロリドン誘導体

Publications (1)

Publication Number Publication Date
MX162717A true MX162717A (es) 1991-02-18

Family

ID=14174668

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2417A MX162717A (es) 1985-05-09 1986-05-08 Procedimiento para la obtencion de un derivado de 2-pirrolidona

Country Status (19)

Country Link
US (1) US4833160A (es)
EP (1) EP0204964B1 (es)
JP (1) JPH066571B2 (es)
KR (1) KR910004789B1 (es)
CN (1) CN1014058B (es)
AT (1) ATE66673T1 (es)
AU (1) AU581078B2 (es)
CA (1) CA1264762A (es)
DE (1) DE3681076D1 (es)
DK (1) DK213286A (es)
ES (1) ES8800148A1 (es)
FI (1) FI84172C (es)
HU (2) HU199117B (es)
MX (1) MX162717A (es)
NO (1) NO861820L (es)
NZ (1) NZ216092A (es)
PH (2) PH23189A (es)
PT (1) PT82540B (es)
ZA (1) ZA863352B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691367A (en) * 1985-08-09 1997-11-25 Eli Lilly And Company Aryl-substituted rhodanine derivatives
US5356917A (en) * 1985-08-09 1994-10-18 Eli Lilly And Company Aryl-substituted rhodanine derivatives
US5202341A (en) * 1987-03-11 1993-04-13 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Hydroxystyrene compounds having tyrosine kinase inhibiting activity
US5089516A (en) * 1987-03-11 1992-02-18 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha 1-phenyl-3,5-pyrazolidinedione hydroxystyrene compounds which have tyrosine kinase inhibiting activity
US4971996A (en) * 1987-03-11 1990-11-20 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Hydroxystyrene compounds which are useful as tyrosine kinase inhibitors
US5216002A (en) * 1989-12-21 1993-06-01 Eli Lilly And Company Method of treating inflammatory bowel disease
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
CA2078790C (en) * 1991-01-21 1998-10-06 Susumu Kamata 3-benzylidene-1-carbamoyl-2-pyrrolidone analogues
US5270339A (en) * 1991-04-05 1993-12-14 Kanagafuchi Kagaku Kogyo Kabushiki Kaisha Phenoxybenzene derivative
DE69301894T2 (de) * 1992-10-28 1996-11-07 Shionogi & Co Benzylidenderivate
US5358964A (en) * 1993-07-26 1994-10-25 Warner-Lambert Company Benzylidene-lactone and their thiocarbonyl analogs as inhibitors of proteoglycan degradation
GB9704499D0 (en) * 1997-03-05 1997-04-23 Glaxo Wellcome Spa Method of manufacture
CN103342672B (zh) * 2013-07-02 2015-12-23 扬州大学 取代吡咯烷-2-酮的新合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714153A (en) * 1970-06-22 1973-01-30 Roussel Uclaf Novel cyclopropanecarboxylic acids
DE2329308A1 (de) * 1972-03-03 1975-01-02 Gruenenthal Chemie Neue lactame
AU518986B2 (en) * 1977-10-11 1981-10-29 Takeda Chemical Industries Ltd. Lactams
US4138495A (en) * 1978-05-19 1979-02-06 Stauffer Chemical Company N-Substituted pyrrolidones and their use as miticides
JPS57130950A (en) * 1981-02-05 1982-08-13 Kanegafuchi Chem Ind Co Ltd 3,5-di-tert-butyl-4-hydroxystyrene derivative and anti- inflammatory, analgesic, antipyretic agent and inhibitor for blood platelet aggregation
US4431656A (en) * 1981-02-05 1984-02-14 Kanegafuchi Chemical Industry Company Limited 3,5-di-Tert-butylstyrene derivatives, salts thereof, and pharmaceutical compositions containing the same as an active ingredient
JPS5879944A (ja) * 1981-11-09 1983-05-13 Kanegafuchi Chem Ind Co Ltd 3,5−ジ・タ−シヤリ−・ブチルスチレン誘導体及び抗炎症、鎮痛、解熱剤並びに血小板凝集阻害剤
US4440784A (en) * 1981-02-05 1984-04-03 Kanegafuchi Chemical Industry Company, Ltd. Anti-inflammatory, analgesic, and antipyretic pharmaceutical composition
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
JPS6112660A (ja) * 1984-06-27 1986-01-21 Kanegafuchi Chem Ind Co Ltd 新規2−ピロリドン誘導体及び抗炎症剤
JPH0623194B2 (ja) * 1985-03-23 1994-03-30 鐘淵化学工業株式会社 新規ラクタム誘導体及び抗炎症剤
JPS6412660A (en) * 1987-07-07 1989-01-17 Canon Kk Original reader
JP3611676B2 (ja) * 1996-06-24 2005-01-19 アサマ化成株式会社 パン生地の改良剤およびパンの製造方法

Also Published As

Publication number Publication date
KR860008973A (ko) 1986-12-19
US4833160A (en) 1989-05-23
CA1264762A (en) 1990-01-23
HU196749B (en) 1989-01-30
KR910004789B1 (ko) 1991-07-13
FI84172C (fi) 1991-10-25
EP0204964B1 (en) 1991-08-28
AU5676686A (en) 1986-11-13
CN1014058B (zh) 1991-09-25
NO861820L (no) 1986-11-10
NZ216092A (en) 1988-08-30
ES8800148A1 (es) 1987-11-01
DK213286D0 (da) 1986-05-07
HUT43040A (en) 1987-09-28
DE3681076D1 (de) 1991-10-02
AU581078B2 (en) 1989-02-09
PH23189A (en) 1989-05-29
ZA863352B (en) 1986-12-30
HUT45493A (en) 1988-07-28
PT82540B (pt) 1988-08-17
FI861698A0 (fi) 1986-04-22
FI861698A (fi) 1986-11-10
FI84172B (fi) 1991-07-15
ATE66673T1 (de) 1991-09-15
EP0204964A1 (en) 1986-12-17
PT82540A (en) 1986-06-01
JPH066571B2 (ja) 1994-01-26
ES554775A0 (es) 1987-11-01
DK213286A (da) 1986-11-10
PH23225A (en) 1989-06-06
HU199117B (en) 1990-01-29
JPS61257967A (ja) 1986-11-15
CN86103227A (zh) 1987-01-21

Similar Documents

Publication Publication Date Title
MX162717A (es) Procedimiento para la obtencion de un derivado de 2-pirrolidona
AU583651B2 (en) Novel nitromethylene derivatives
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
ES2101960T3 (es) Lactamas benzo-condensadas.
DE69428703D1 (de) Pyrrolidin derivate
EP0534396A3 (en) Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace
MX9102582A (es) Derivados de indol 3,7-disubstituidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ES2133430T3 (es) Derivados de n-heteroaril-n-fenilurea, su preparacion y utilizacion.
ATE112558T1 (de) Glycosidasehemmer.
ES2174298T3 (es) Derivados de aminotiazol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
JPS5463086A (en) 33*22hydroxyy44*substituted*phenyl* azacycloalkane as analgesic*its derivative and intermediate
ES556914A0 (es) Procedimiento de obtencion de derivados de n-fenil-3,4,5,6-tetrahidroftalimida
ES2024688B3 (es) Portaguillotina perfeccionada para focos cerrados de chimeneas.
ES539777A0 (es) Procedimiento para la produccion de indolofenantridinas
DE3873562D1 (de) Beta-alkylmelatonine.
NO860148L (no) N-substituerte butyramidderivater.
ATE197950T1 (de) Guanidylmethyl cyclohexancarbonsäure ester derivate
PT946548E (pt) Novos derivados de pirrolidino amida substituidos por heterociclos
FR2693723B1 (fr) Dérivés de la N-(phényléthyl-beta-ol) amine ainsi que leur procédé de préparation.
ES512564A0 (es) "un procedimiento para la preparacion enantioselectiva de derivados n-sustituidos de prolina".
ES2039270T3 (es) Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos.
HU9500944D0 (en) N,n-substituted amino-methylen-imidazolinone derivatives as intermediates of 2-substituted 5-chloro-imidazol-4-carbaldeydes